Shirahase H, Kanda M, Nakamura S, Tarumi T, Uehara Y, Ichikawa A
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd., Japan.
Life Sci. 2000 Apr 21;66(22):2173-82. doi: 10.1016/s0024-3205(00)00544-0.
PGD2 and its metabolites PGJ2 and 15-deoxy-delta12,14-PGJ2 have been reported to inhibit iNOS induction in cultured vascular smooth muscle cells. The present study was undertaken to determine whether these prostanoids inhibit iNOS induction in the isolated rat mesenteric artery. The artery without endothelium was incubated with and without lipopolysaccharide (LPS) at 37 degrees C for 6 hrs, then washed and mounted in an organ bath to measure isometric changes in tension. L-arginine but not D-arginine (10(-6) - 10(-3) M) induced concentration-dependent relaxations only in the artery preincubated with LPS, the relaxations of which were attenuated by L-N(G)-nitroarginine methyl ester (LNAME, 10(-4) M), a non-selective iNOS inhibitor, and 1400W (10(-5) and 10(-4) M), a selective iNOS inhibitor. Co-treatment of cycloheximide (10(-5) M), a protein synthesis inhibitor, or actinomycin D (10(-7) M), an RNA synthesis inhibitor with LPS inhibited the development of relaxing ability in response to L-arginine, indicating iNOS induction by LPS. PGD2, PGJ2 and 15-deoxy-delta12,14-PGJ2 but not PGE2, PGI2 or PGF2alpha also inhibited the development of relaxing ability in response to L-arginine when added during incubation with LPS. Incubation of the artery with LPS at 37 degrees C for 6 hrs markedly increased production of nitric oxide (NO), which was abolished by 15-deoxy-delta12,14-PGJ2 (10(-5) M). An imunohistochemical study using antibody against murine iNOS showed that 15-deoxy-delta12,14-PGJ2 (10(-5) M) inhibited the expression of iNOS protein in isolated rat mesenteric arteries. These results demonstrated that PGD2 and its metabolites inhibit iNOS induction by LPS in isolated rat mesenteric arteries, resulting in reduced relaxing ability in response to L-arginine.
据报道,前列腺素D2(PGD2)及其代谢产物前列腺素J2(PGJ2)和15-脱氧-Δ12,14-前列腺素J2(15-deoxy-Δ12,14-PGJ2)可抑制培养的血管平滑肌细胞中诱导型一氧化氮合酶(iNOS)的表达。本研究旨在确定这些前列腺素是否能抑制离体大鼠肠系膜动脉中iNOS的诱导。将无内皮的动脉在37℃下分别与脂多糖(LPS)一起孵育和不与LPS一起孵育6小时,然后冲洗并安装在器官浴槽中以测量等长张力变化。L-精氨酸(而非D-精氨酸,10⁻⁶ - 10⁻³ M)仅在预先用LPS孵育的动脉中诱导浓度依赖性舒张,其舒张作用被非选择性iNOS抑制剂L-N(G)-硝基精氨酸甲酯(LNAME,10⁻⁴ M)和选择性iNOS抑制剂1400W(10⁻⁵和10⁻⁴ M)减弱。蛋白质合成抑制剂环己酰亚胺(10⁻⁵ M)或RNA合成抑制剂放线菌素D(10⁻⁷ M)与LPS共同处理可抑制对L-精氨酸反应的舒张能力的发展,表明LPS可诱导iNOS。在与LPS孵育期间添加PGD2、PGJ2和15-脱氧-Δ12,14-PGJ2(而非前列腺素E2、前列环素I2或前列腺素F2α)也可抑制对L-精氨酸反应的舒张能力的发展。将动脉在37℃下与LPS孵育6小时可显著增加一氧化氮(NO)的产生,而15-脱氧-Δ12,14-PGJ2(10⁻⁵ M)可消除这种增加。使用抗小鼠iNOS抗体的免疫组织化学研究表明,15-脱氧-Δ12,14-PGJ2(10⁻⁵ M)可抑制离体大鼠肠系膜动脉中iNOS蛋白的表达。这些结果表明,PGD2及其代谢产物可抑制LPS在离体大鼠肠系膜动脉中诱导iNOS,从而导致对L-精氨酸反应的舒张能力降低。